UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 216

Sortiert nach

A clinical study assessing the tolerability and biological effects of infliximab, a TNF-α inhibitor, in patients with advanced cancer

Annals of oncology, 2008-07, Vol.19 (7), p.1340-1346

2008

Volltextzugriff (PDF)

Quantitative assessment of the leukocyte infiltrate in ovarian cancer and its relationship to the expression of C-C chemokines

The American journal of pathology, 1997-05, Vol.150 (5), p.1723-1734

1997

Volltextzugriff (PDF)

Experimental validation of a flat punch indentation methodology calibrated against unconfined compression tests for determination of soft tissue biomechanics

Journal of the mechanical behavior of biomedical materials, 2016-07, Vol.60, p.401-415

2016

Volltextzugriff (PDF)

Activity of type IV collagenases in benign and malignant breast disease

British journal of cancer, 1993-05, Vol.67 (5), p.1126-1131

1993

Volltextzugriff (PDF)

Regulation of monocyte MMP-9 production by TNF-α and a tumour-derived soluble factor (MMPSF)

British journal of cancer, 1998-09, Vol.78 (6), p.724-732

1998

Volltextzugriff (PDF)

MMP-2 release and activation in ovarian carcinoma: the role of fibroblasts

British Journal of Cancer, 1999-05, Vol.80 (3-4), p.315-321

1999

Volltextzugriff (PDF)

Tumor necrosis factor and its receptors in human ovarian cancer : potential role in disease progression

The Journal of clinical investigation, 1993-05, Vol.91 (5), p.2194-2206

1993

Volltextzugriff (PDF)

Tumour necrosis factor α: a potential target for the therapy of solid tumours

The lancet oncology, 2003-09, Vol.4 (9), p.565-573

2003

Volltextzugriff (PDF)

Expression and activity of MMPS and their regulators in ovarian cancer

International journal of cancer, 1994-07, Vol.58 (1), p.50-56

1994

Volltextzugriff (PDF)

The detection and localization of monocyte chemoattractant protein-1 (MCP-1) in human ovarian cancer

The Journal of clinical investigation, 1995-05, Vol.95 (5), p.2391-2396

1995

Volltextzugriff (PDF)

A synthetic matrix metalloproteinase inhibitor decreases tumor burden and prolongs survival of mice bearing human ovarian carcinoma xenografts

Cancer research (Chicago, Ill.), 1993-05, Vol.53 (9), p.2087-2091

1993

Volltextzugriff (PDF)

Hypoxia down-regulates MCP-1 expression: implications for macrophage distribution in tumors

Journal of leukocyte biology, 1998-06, Vol.63 (6), p.758-765

1998

Volltextzugriff (PDF)

Measuring cytokine levels in blood: Importance of anticoagulants, processing, and storage conditions

Journal of immunological methods, 1992-08, Vol.153 (1), p.115-124

1992

Volltextzugriff (PDF)

Cytotoxic response of ovarian cancer cell lines to IFN-γ is associated with sustained induction of IRF-1 and p21 mRNA

British journal of cancer, 1999-06, Vol.80 (8), p.1236-1244

1999

Volltextzugriff (PDF)

Inhibition of monocyte and macrophage chemotaxis by hypoxia and inflammation – a potential mechanism

European journal of immunology, 2001-02, Vol.31 (2), p.480-489

2001

Volltextzugriff (PDF)

Interferon gamma induces cell cycle arrest and apoptosis in a model of ovarian cancer: Enhancement of effect by batimastat

European journal of cancer (1990), 1997-06, Vol.33 (7), p.1114-1121

1997

Volltextzugriff (PDF)

Exploiting changes in the tumour microenvironment with sequential cytokine and matrix metalloprotease inhibitor treatment in a murine breast cancer model

British Journal of Cancer, 2000-12, Vol.83 (11), p.1538-1543

2000

Volltextzugriff (PDF)

Zymography: A Single-Step Staining Method for Quantitation of Proteolytic Activity on Substrate Gels

Analytical biochemistry, 1997-06, Vol.249 (1), p.24-28

1997

Volltextzugriff (PDF)

Cells secreting tumour necrosis factor show enhanced metastasis in nude mice

European journal of cancer & clinical oncology, 1990, Vol.26 (10), p.1031-1034

1990

Volltextzugriff (PDF)

Expression of tumour necrosis factor (TNFα) and its receptors in benign and malignant breast tissue

International journal of cancer, 1994-03, Vol.56 (6), p.777-782

1994

Volltextzugriff (PDF)

Changes in endogenous cytokines, adhesion molecules and platelets during cytokine-induced tumour necrosis

British journal of cancer, 1995-11, Vol.72 (5), p.1165-1172

1995

Volltextzugriff (PDF)

Paradoxical effects of tumour necrosis factor in experimental ovarian cancer

International journal of cancer, 1989-11, Vol.44 (5), p.918-925

1989

Volltextzugriff (PDF)

Human tumor xenografts treated with recombinant human tumor necrosis factor alone or in combination with interferons

Cancer research (Chicago, Ill.), 1986-08, Vol.46 (8), p.3990-3993

1986

Volltextzugriff (PDF)

Positive interactions between human interferon and cyclophosphamide or adriamycin in a human tumor model system

Cancer research (Chicago, Ill.), 1984-03, Vol.44 (3), p.904-908

1984

Volltextzugriff (PDF)

Effects of interferons and other cytokines on tumors in animals: A review

Pharmacology & therapeutics (Oxford), 1991-12, Vol.52 (3), p.307-330

1991

Volltextzugriff (PDF)

1 – 25 von 216

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(193)
Mit Volltextzugriff
(190)

Publikationsform

Sprache

Englisch
(216)
Japanisch
(27)

Erscheinungsjahr

n.n

Thema

Science & Technology
(150)
Life Sciences & Biomedicine
(145)
Humans
(123)
Biological And Medical Sciences
(92)
Female
(87)
Oncology
(83)
Animals
(79)
Medical Sciences
(72)
Mice
(63)
Pharmacology. Drug Treatments
(42)
Antineoplastic Agents
(38)
Tumors
(36)
Mice, Nude
(33)
Neoplasm Transplantation
(28)
Ovarian Neoplasms - Pathology
(24)
Transplantation, Heterologous
(23)
Fundamental And Applied Biological Sciences. Psychology
(21)
Middle Aged
(20)
Adult
(19)
Immunology
(19)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

A clinical study assessing the tolerability and biological effects of infliximab, a TNF-α inhibitor, in patients with advanced cancer

Quantitative assessment of the leukocyte infiltrate in ovarian cancer and its relationship to the expression of C-C chemokines

Experimental validation of a flat punch indentation methodology calibrated against unconfined compression tests for determination of soft tissue biomechanics

Activity of type IV collagenases in benign and malignant breast disease

Regulation of monocyte MMP-9 production by TNF-α and a tumour-derived soluble factor (MMPSF)

MMP-2 release and activation in ovarian carcinoma: the role of fibroblasts

Tumor necrosis factor and its receptors in human ovarian cancer : potential role in disease progression

Tumour necrosis factor α: a potential target for the therapy of solid tumours

Expression and activity of MMPS and their regulators in ovarian cancer

The detection and localization of monocyte chemoattractant protein-1 (MCP-1) in human ovarian cancer

A synthetic matrix metalloproteinase inhibitor decreases tumor burden and prolongs survival of mice bearing human ovarian carcinoma xenografts

Hypoxia down-regulates MCP-1 expression: implications for macrophage distribution in tumors

Measuring cytokine levels in blood: Importance of anticoagulants, processing, and storage conditions

Cytotoxic response of ovarian cancer cell lines to IFN-γ is associated with sustained induction of IRF-1 and p21 mRNA

Inhibition of monocyte and macrophage chemotaxis by hypoxia and inflammation – a potential mechanism

Interferon gamma induces cell cycle arrest and apoptosis in a model of ovarian cancer: Enhancement of effect by batimastat

Exploiting changes in the tumour microenvironment with sequential cytokine and matrix metalloprotease inhibitor treatment in a murine breast cancer model

Zymography: A Single-Step Staining Method for Quantitation of Proteolytic Activity on Substrate Gels

Cells secreting tumour necrosis factor show enhanced metastasis in nude mice

Expression of tumour necrosis factor (TNFα) and its receptors in benign and malignant breast tissue

Changes in endogenous cytokines, adhesion molecules and platelets during cytokine-induced tumour necrosis

Paradoxical effects of tumour necrosis factor in experimental ovarian cancer

Human tumor xenografts treated with recombinant human tumor necrosis factor alone or in combination with interferons

Positive interactions between human interferon and cyclophosphamide or adriamycin in a human tumor model system

Effects of interferons and other cytokines on tumors in animals: A review

Suchergebnisse filtern